Rehues Masip, P. (2025). Advanced lipidomics and metabolomics to study atherogenic dyslipidemia in relation to type 2 diabetes and cardiovascular disease: The role of apolipoprotein C-III.
Citación estilo ChicagoRehues Masip, Pere. Advanced Lipidomics and Metabolomics to Study Atherogenic Dyslipidemia in Relation to Type 2 Diabetes and Cardiovascular Disease: The Role of Apolipoprotein C-III. 2025.
Cita MLARehues Masip, Pere. Advanced Lipidomics and Metabolomics to Study Atherogenic Dyslipidemia in Relation to Type 2 Diabetes and Cardiovascular Disease: The Role of Apolipoprotein C-III. 2025.
Precaución: Estas citas no son 100% exactas.